Kolexia
Graff-Cailleaud Pierre Oncologie radiothérapie
Graff-Cailleaud Pierre
Oncologie radiothérapie
Institut Curie
Saint-Cloud, France
128 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la tête et du cou Tumeurs de la prostate Carcinomes Carcinome épidermoïde Carcinome épidermoïde de la tête et du cou Tumeurs de l'oropharynx Récidive tumorale locale Tumeurs de la vessie urinaire Tumeurs de la bouche

Collaborateurs

Voir plus
Latorzeff Igor
Latorzeff Igor
Hôpital Rangueil, Toulouse, France
Khalifa Jonathan
Khalifa Jonathan
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
Supiot Stephane
Supiot Stephane
Institut de cancérologie de l'Ouest, Saint-Herblain, France
Sargos Paul
Sargos Paul
Institut Bergonié, Bordeaux, France

Industries

Voir plus
Ipsen
17 collaboration(s)
Dernière en 2023
Astellas
7 collaboration(s)
Dernière en 2023
Janssen
4 collaboration(s)
Dernière en 2023
A+A
2 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
TEMPOS: Erectile Dysfunction in Good Prognosis Prostate Cancer: a Phase III Medico-economic Study Comparing Brachytherapy to Stereotactic Body Radiotherapy
Essai Clinique (Centre Eugène Marquis)   06 février 2024
Bladder-ART: Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer: A Randomized Multicentre Phase II Study
Essai Clinique (Unicancer)   09 novembre 2023
GETUG-StORM-01: A Randomized Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases
Essai Clinique (Centre François-Baclesse)   31 juillet 2023
Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer: Randomized, Multicenter Study Comparing the Immediate Adjuvant Radiotherapy Associate With Hormonal Therapy of LH-RH Analogue (Decapeptyl® LP) vs Delayed Radiotherapy Until Biochemical Relapse Associated With Hormonal Therapy of LH-RH Analogue (Decapeptyl® LP) in Patients With Operable Prostate Cancer pT3 R1 pN0 or pNx at Intermediate Risk.
Essai Clinique (Ipsen)   13 avril 2023
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis.
Cancers   11 février 2023
AIRO GORTEC consensus on postoperative radiotherapy (PORT) in low-intermediate risk early stages oral squamous cell cancers (OSCC).
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   03 novembre 2022
Challenges and limits of therapeutic de-escalation for papillomavirus-related oropharyngeal cancer.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   24 août 2022
Dose-escalation in prostate cancer: Results of randomized trials.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique   24 août 2022
Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey.
Clinical and translational radiation oncology   08 août 2022
Stereotactic Radiation Therapy versus Brachytherapy: Relative Strengths of Two Highly Efficient Options for the Treatment of Localized Prostate Cancer.
Cancers   29 avril 2022